CGTI. Cell & Gene Innovation Summit 2027
10–11 February 2027 · Location · TBA · Invited Audience Only
For the patients. We must do better.
Leadership must keep pace to evolve and stay competitive.
Senior leaders advancing cell and gene therapy from clinical promise to manufacturing reality.
01 · CGTI.ai
CGT Innovation Leaders Dialogue 2027
The four pillars of CGTI.ai
AI‑enabled bioprocessing
Why it matters: It makes AI a trusted co‑pilot for complex CGT batches – stabilising autologous and allogeneic processes, cutting batch failure, and speeding right‑first‑time release from vein to vein.
Agile capacity and networks
Why it matters: It lets CGT leaders design modular, distributed networks – from in‑house suites to specialist CDMOs – that can follow patients and indications without breaking comparability.
Workforce and human systems
Why it matters: It protects scarce CGT talent, turning operators, MSAT and QA into AI‑literate decision‑makers who can trust, challenge and improve digital twins and algorithms on the shop floor.
Sustainable resilient operations
Why it matters: It hard‑wires resilience into CGT – from starting‑material security to cold‑chain and chain‑of‑identity – so therapies stay available, affordable and inspection‑ready as volumes grow.
02 · THE GAP
Curated for senior ops & manufacturing leaders
Why it Matters.
In 2027, AI, automation and digital bioprocessing are moving from pilots into the heart of cell and gene therapy manufacturing.
At the same time, companies are committing record capital to new CGT facilities and regional networks while facing tight margins, skills gaps and rising sustainability expectations.
The question is no longer whether these shifts are coming, but how to deploy them in CGT without breaking cost, compliance or supply.
Cell Biology at Scale.
Three Industries.
One Question.
How Do We Turn Cells into Scalable Solutions?
03 · WHO IT'S CURATED FOR
CGTI is a curated, invite-only room for senior decision-makers from cell and gene therapy, biologics and adjacent bioprocessing who are committing to the next wave of capacity, technology and workforce transformation.
MANUFACTURING & OPERATIONS
VP Manufacturing · COO · Site Director · Head of Operations
For technology partners and CDMOs, CGTI is where manufacturing strategy becomes multi-year deployment commitment.
Quality & Regulatory
VP Quality · Head of QA · Chief Quality Officer · RA Lead
It is a curated, invite‑only meeting for senior decision makers from biologics, cell and gene therapy and cultivated protein who sign off the next wave of capacity, technology and partnership commitments.
MSAT & PROCESS DEVELOPMENT
Head of MSAT · VP Tech Ops · Process Development Lead
Over two days, conversation stays close to four pillars — AI-enabled bioprocessing, agile capacity and networks, workforce and human systems, sustainable resilient operations — because those are where 2027 decisions land.
DIGITAL, DATA & R&D
VPs Innovation · VP Digital · Head of Data Science Digital Transformation Lead · Heads of R&D · Automation · Infrastructure
For operators, it is a room to pressure-test approaches with peers facing identical constraints — cost, compliance, supply and the patient at the end of the chain.
Advisory Circle.
Advisory & Past Speakers
